Form 4 for G Genpact LTD
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001567619-23-003619 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-23 | 2023-02-21 | G | Kalra Balkrishan | SVP | S - Sale+OE | $47.99 | -25.0K | 154.8K | -14% | -$1.20M |
| D | 2023-02-23 | 2023-02-21 | G | Kalra Balkrishan | SVP | M - OptEx | $19.35 | +25.0K | 179.8K | +16% | +$483.8K |
| D | 2023-02-23 | 2023-02-21 | G | Kalra Balkrishan | SVP | M - OptEx | $0.00 | -25.0K | 42.3K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-02-21 | S | D | 25,000 | $47.99 | 154,788 | D | — | — | (F1) The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.95 to $48.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Shares | 2023-02-21 | M | A | 25,000 | $19.35 | 179,788 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-02-21 | M | D | 25,000 | $0.00 | 42,280 | D | $19.35 · — to 2023-05-30 | 25,000 Common Shares | (F2) The option vested 50% on January 10, 2016 and 50% on January 10, 2018. |